Penumbra INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
Penumbra, Inc. has announced its 2026 Annual Meeting of Stockholders and a definitive merger agreement with Boston Scientific Corporation.
NYSE
Penumbra, Inc. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
NYSE
Penumbra, Inc. is holding its annual meeting on May 28, 2025, to vote on director elections, auditor ratification, executive compensation, and amendments to the company's charter regarding board declassification and supermajority voting requirements.
NYSE
Penumbra, Inc. has filed definitive additional materials related to its proxy statement with the Securities and Exchange Commission.
NYSE
Penumbra, Inc. has scheduled its 2024 Annual Meeting of Stockholders for June 5, 2024, to elect directors, ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approve executive compensation on an advisory basis.